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OBJECTIVE — To determine whether multiparity is associated with type 2 diabetes, inde-
pendent of visceral adipose tissue (VAT) and adipokines.
RESEARCH DESIGN AND METHODS — Participants were from the University of
California San Diego Filipino Women’s Health Study with at least one live birth. A 2-h 75-g oral
glucose tolerance test was administered; adiponectin, leptin, ghrelin, reproductive history, fam-
ily history of diabetes, VAT, and lifestyle behaviors were measured between 1995 and 2002.
RESULTS — Among 152 women, mean age was 59.5 years (range 48–73 years) and mean
parity was 4.3 (range 1–12 births). Type 2 diabetes prevalence increased by parity group (low
parity, 1–2 births, 25%; medium parity, 3–5 births, 30.3%; and grand multiparity: 6–12 births,
50%; P  0.048). Family history of diabetes, exercise, insulin resistance, and leptin and ghrelin
levels did not differ by parity group. Compared with women in the low parity group, women
with 6 births were signiﬁcantly older (62 vs. 57 years), had lower college completion (22 vs.
58%, P  0.006), more hypertension (72 vs. 55%), higher VAT (74.9 vs. 58.4 cm
3), and lower
adiponectinconcentration(5.79vs.7.61g/ml).Inmultivariateanalysisadjustingforadiponec-
tin, VAT, family history of diabetes, age, education, hypertension, and estrogen use, grand
multiparous women had a threefold higher odds of type 2 diabetes (adjusted odds ratio 3.40
[95% CI 1.13–10.2]) compared with low parity women. No differences were observed in the
odds of diabetes between women in the medium (1.10 [0.41–2.91]) and low parity groups.
CONCLUSIONS — Having6childrenwasassociatedwithtype2diabetes,independentof
adiponectin, VAT, family history, and other measured diabetes risk factors.
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P
rior studies have reported elevated
type 2 diabetes prevalence among
multiparous women (1–5); how-
ever, the elevated risk has been attributed
to postpartum weight retention (1,2).
Other studies have shown that the excess
diabetes risk in multiparous women per-
sisted after adjustment for anthropomet-
ric factors (3–5) as well as lifestyle,
reproductive, and inﬂammatory factors
(3,4).
Visceraladiposetissue(VAT)isanac-
tive endocrine organ and is an important
determinant of type 2 diabetes. Estimates
of obesity including BMI, waist girth,
waist-to-hip ratio, and truncal fat by dual
energy x-ray absorptiometry do not dis-
tinguish VAT from subcutaneous adipose
tissue (SAT), whereas computed tomog-
raphy provides a direct estimate of VAT
and SAT. Excess VAT accumulation con-
tributes to changes in the production or
action of adipocytokines, including adi-
ponectin, resistin, leptin, tumor necrosis
factor-, and C-reactive protein (6). Adi-
ponectin, an adipocyte-secreted protein
with insulin-sensitizing effects, is in-
versely associated with VAT, and low lev-
els are predictive of type 2 diabetes even
among populations without generalized
obesity, such as Japanese and Asian Indi-
ans(7–10).Leptinregulatesappetitecon-
trol and energy metabolism, is strongly
correlated with obesity, and may play a
major role in islet cell growth and insulin
secretion (11,12). Ghrelin, a peptide hor-
mone secreted by the stomach, regulates
hunger and long-term weight gain or loss
and is thought to play a role in glucose
homeostasis and insulin resistance (13).
Plasma ghrelin concentrations are lower
in persons with obesity, hypertension,
and type 2 diabetes (14,15).
Prior studies have reported VAT in-
creases with higher parity, independent
ofpercentbodyfatamongwomenwith-
out diabetes, endocrine disorders, or
cardiovascular disease (16), but
whether VAT or adipocyte-derived pro-
teins mediate the association between
multiparity and type 2 diabetes has not
been evaluated.
Filipinos in the Philippines, Hawaii,
and California have an elevated preva-
lence of type 2 diabetes, despite the ab-
sence of general obesity (17–19). In
addition, Filipino American women in
San Diego had excess VAT despite having
BMI, waist girth, and percent total body
and truncal fat similar to those of Cauca-
sian women, and signiﬁcantly lower
anthropometric markers than African
American women (20). Type 2 diabetes
prevalence was 32.1% among Filipinas
compared with 5.8% among Caucasian
women with similar BMI, waist girth and
percentage of truncal fat; when limited to
women in the lowest VAT category, the
excess diabetes prevalence among Filipi-
nas(22.8%)persistedcomparedwiththat
in Caucasian (1.7%) and African Ameri-
can women (12.1%) (20). Among
normoglycemic women, Filipinas had
signiﬁcantly lower concentrations of adi-
ponectin and ghrelin compared with
those in normoglycemic Caucasian
women,evenafteradjustmentforanthro-
pometric markers and insulin resistance
(21).
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type 2 diabetes, primarily though post-
partumweightretention;however,theas-
sociation with VAT and adipokines has
notbeenelucidated,particularlyinnono-
bese, highly parous populations. The ob-
jective of this study was to determine
whether multiparity is associated with
type 2 diabetes, independent of visceral
fat, adipokines, and other measured dia-
betes risk factors.
RESEARCH DESIGN AND
METHODS— The Rancho Bernardo
Study, a San Diego community-based
longitudinal study of multiple health out-
comes since 1972, includes participants
who are predominantly non-Hispanic
Caucasians. Between 1995 and 1999, an
ethnic comparison cohort of Filipino
women was enrolled (19). Population-
based sampling was not possible because
Filipinos were not identiﬁed separately
from Asians in the 1990 census; conse-
quently, a convenience sample was re-
cruited, as described elsewhere (19).
Clinical evaluations were performed at
the University of California San Diego
Rancho Bernardo Clinic between 1995
and 1999. Participants without known
cardiovascular disease (by history, elec-
trocardiogram abnormalities, or angina
pectoris by Rose questionnaire) or coro-
nary revascularization surgery were in-
vited between 2001 and 2002 to measure
coronary artery calcium as well as VAT
and SAT. The study was approved by the
University of California San Diego Hu-
man Research Protections Program, and
all women provided written informed
consent.
Clinical evaluation
Demographic characteristics, lifestyle
(cigarette smoking, alcohol use, and
physical activity), physician-diagnosed
conditions, and menopausal status were
determined using structured question-
naires. Reproductive history was assessed
byaself-administeredquestionnaire.Par-
ticipants who were using prescription or
nonprescription medications in the
month before the clinic visit brought pills
and prescriptions to the clinic to be veri-
ﬁed and recorded by a nurse. None of the
participants were taking thiazolidinedio-
nes, which have been shown to alter adi-
ponectin concentration.
Height and weight were measured in
participants wearing lightweight clothing
without shoes. BMI (weight in kilograms
divided by the square of height in meters)
was computed as an estimate of general
obesity. Waist circumference was mea-
sured at the natural bending point; hip
circumference was measured at the iliac
crest. VAT and SAT were measured by
electron beam computed tomography
(Imatron C-150 scanner; GE Healthcare)
with three slices between L4 and L5.
A 75-g oral glucose tolerance test was
administered after a minimum 8-h over-
night fast; blood samples were obtained
by venipuncture at 0 and 2 h. Plasma glu-
cosewasmeasuredbytheglucoseoxidase
method, and insulin was determined by
radioimmunoassay in a diabetes research
laboratory. Homeostasis model assess-
ment was used to estimate insulin resis-
tance (HOMA-IR) and -cell function
(HOMA-). Type 2 diabetes was deﬁned
using the 1999 World Health Organiza-
tion criteria: fasting plasma glucose level
126 mg/dl, or 2-h postchallenge glu-
coselevel200mg/dl,orahistoryoftype
2 diabetes diagnosed by a physician, or
treatment with an oral hypoglycemic
agent or insulin. Two morning blood
pressure readings were recorded with a
mercury sphygmomanometer using the
Hypertension Detection and Follow-up
Program protocol. Hypertension was de-
ﬁned as systolic blood pressure 130
mm Hg or diastolic blood pressure 85
mmHg or use of antihypertensive medi-
cation. Fasting adiponectin, leptin, and
ghrelin concentrations were measured by
radioimmunoassay (Linco Research, St.
Louis, MO) in 2004 using archived sam-
plesthathadbeenstoredfrozenat70°C
and not previously thawed.
Statistical analysis
Nulliparous women were excluded to ex-
clude those who might have had polycys-
tic ovary disease, a known risk factor for
diabetes.Parity,deﬁnedaslivebirths,was
analyzedasacontinuousvariableandfur-
therclassiﬁedintolowparity(1–2births),
medium parity (3–5 births), and grand
multiparity (6–12 births) groups. Data
were analyzed using SAS (version 9.1,
SAS Institute, Cary, NC). Analysis of vari-
ance, general linear models, and 
2 tests
were used for descriptive statistics. Gen-
eral linear models were used to compare
mean levels of each anthropometric
marker, while adjusting for age and dia-
betes. The distributions of adiponectin,
leptin, and ghrelin were skewed and con-
sequentlywerelog-transformedforstatis-
tical analysis; geometric mean levels of
these proteins are reported. Univariate
analysiswasperformedtoidentifycovari-
ates associated with diabetes. Multivari-
able logistic regression was performed to
identify covariates associated with type 2
diabetes and to compare the odds of type
2 diabetes by parity category, using the
low parity category as the referent group.
Covariates included in the multivariable
modelsconsistedofvariablesthatdiffered
by parity group and those associated with
diabetes in univariate analysis. Statistical
signiﬁcance was designated at P  0.05
and 95% conﬁdence intervals that ex-
cluded 1.
RESULTS— The study population in-
cluded 152 parous Filipino American
women with a mean age of 59.5 years
(range 48–73 years); the majority were
immigrants (99%), were well educated
(44% were college graduates), and en-
gaged in healthy behaviors. Only 14%
had ever smoked, 1% had 3 alcoholic
drinks per week, and 71% reported exer-
cising at least three times per week. Mean
BMIwas25.4kg/m
2andmeanwaistgirth
was 81.4 cm, and one-third (33.6%) had
type 2 diabetes. One fourth (n  39,
25.7%) had at least one biological parent
withtype2diabetes;ofthese,18hadboth
abiologicalparentandsiblingwithtype2
diabetes.Anadditional14women(9.2%)
hadasibling(diagnosedafterage45)with
type 2 diabetes but did not have an af-
fected biological parent, for a total of
34.9% who had a family history of type 2
diabetes. The number of live births
ranged from 1 to 12 births (mean 4.3 live
births), and one-fourth had grand multi-
parity (6 live births; mean 8.1 births).
When stratiﬁed by parity group,
mean age increased with increasing par-
ity, where women with 6 children were
signiﬁcantly older (mean age 62.4 years
compared with 57.1 years for those who
boreoneortwochildren(P0.001)(Ta-
ble 1). Women with grand multiparity
had lower college completion and estro-
gen use (22.2% and 2.8%, respectively)
compared with women with medium
(47.4% completed college and 26.3%
used estrogen) or low parity (57.5% and
32.5%). Grand multiparous women had
signiﬁcantly higher fasting and 2-h glu-
cose levels; however, fasting and 2-h in-
sulin levels, HOMA-IR, and HOMA-
levels, family history of type 2 diabetes,
and exercise (3 times/week) frequency
did not vary by parity category (Table 1).
The prevalence of hypertension and type
2 diabetes increased signiﬁcantly by par-
itycategory;diabetesprevalencewas25%
in the low parity group, 30.3% in the me-
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women with 6 births (P  0.048).
Age-adjusted mean BMI, waist girth,
and VAT were signiﬁcantly lower in
women in the low parity group compared
with women in either the medium parity
or grand multiparity group, but did not
differ between the medium parity and
grandmultiparitygroup(Table2).Waist-
to-hip ratio was signiﬁcantly smaller in
women with one to two children than in
those with 6 children but did not differ
from that for the medium parity group.
Subcutaneous fat was signiﬁcantly lower
in the low parity group than in women
with three to ﬁve children but did not
differ from that in grand multiparous
women. Adiponectin was inversely asso-
ciated with obesity and was signiﬁcantly
lower in the medium parity and grand
multiparity groups than that in women
with lower parity. Age-adjusted ghrelin
and leptin levels did not differ by parity
category.
These observations persisted after ad-
justment for both age and diabetes with
the exception of BMI and adiponectin.
BMI did not differ by parity group after
adjustment for age and diabetes, whereas
adiponectin was signiﬁcantly lower in the
medium parity group but did not differ
between the low parity and grand multi-
parity categories. Neither ghrelin nor lep-
tin levels varied by parity category after
adjustment for age and diabetes.
Stepwise logistic regression showed
that parity (adjusted odds ratio [OR] 1.27
[95% CI 1.09–1.49], P  0.0027) was
independently associated with type 2 di-
abetes after adjustment for adiponectin
concentration,VAT,familyhistoryoftype
2 diabetes, hypertension, age, current es-
trogen use, and education (Table 3,
model 1). Furthermore, family history of
diabetes (5.03 [2.18 11.60]), hyperten-
sion (3.16 [1.33–7.55]), and low adi-
ponectin (log) levels (0.45 [0.22–0.94])
were also independently associated with
type 2 diabetes. Age, visceral adiposity,
education, and estrogen use were not as-
sociated with type 2 diabetes. These ob-
servations persisted when women were
categorized by parity group. Compared
with women in the low parity group,
women who had 6 live births had a
threefold higher odds (3.40 [1.13–10.2])
of having type 2 diabetes, independent of
adiponectin concentration, VAT, family
history of type 2 diabetes, hypertension,
age,estrogenuse,andeducation(Table3,
model 2). Similarly, family history of type
2 diabetes, hypertension, and low adi-
ponectin concentration were indepen-
dently associated with type 2 diabetes.
Women in the medium parity group did
not have an increased risk of type 2 dia-
betes (1.10 [0.41–2.91]) compared with
women in the low parity group after ad-
justmentfortheabovecovariates.Neither
ghrelin nor leptin was associated with
type 2 diabetes in multivariable models
that included these proteins (data not
shown).
Family history of diabetes was an im-
portant correlate of type 2 diabetes; how-
ever,neithermeanadiponectin,BMI,waist,
nor VAT differed among those with versus
those without a family history of diabetes.
Table 1—Age-adjusted demographic and clinical characteristics, by parity category, Filipino
American women, San Diego, California, 1995–2002
Number of live births
1–2 3–5 6–12 P value
n 40 76 36
Age (years) 57.1 59.5 62.4 0.001
College graduate (%) 57.5 47.4 22.2 0.006
Family history diabetes (%) 40.0 35.5 27.8 0.528
Exercise (3 times/week, %) 70.0 72.4 69.4 0.940
Estrogen use (current, %) 32.5 26.3 2.8 0.004
Fasting glucose (mmol/l) 5.41 5.93 6.79 0.046
2-h glucose (mmol/l) 8.69 10.09 12.09 0.029
Fasting insulin (pmol/l) 80.94 74.59 76.24 0.947
2-h insulin (pmol/l) 435.63 576.36 542.39 0.157
HOMA-IR 2.98 3.03 3.25 0.929
HOMA- index 119.71 113.27 96.85 0.438
Hypertension (%) 55.0 64.5 72.2 0.029
Type 2 diabetes (%) 25.0 30.3 50.0 0.048
Data are means or frequency distribution.
Table 2—Anthropometric characteristics, adjusted for age and type 2 diabetes, by parity
category, Filipino American women, San Diego, California
Number of live births
1–2 3–5 6–12
n 40 76 36
BMI (kg/m
2) 24.55 25.71 25.85
Waist circumference (cm) 78.34 82.89* 83.04†
Waist-to-hip ratio 0.823 0.837 0.859†
VAT (cm
3) 59.39 72.12* 73.19†
SAT (cm
3) 140.73 163.03* 158.94
Adiponectin (g/ml) 7.45 5.67* 6.02
Ghrelin (pg/ml) 1,072.0 1,084.7 1,039.6
Leptin (ng/ml) 12.38 14.72 13.63
Data are means. *P  0.05, 3–5 vs. 1–2 live births. †P  0.05, 6–12 vs. 1–2 live births.
Table 3—Stepwise logistic regression: co-
variates associated with type 2 diabetes
among parous Filipino American women
Covariate
Adjusted OR
(95% CI)
P
value
Model 1
Parity 1.27 (1.09–1.49) 0.0027
Adiponectin
(log) 0.45 (0.22–0.94) 0.0335
Family history
of diabetes 5.03 (2.18–11.6) 0.0001
Hypertension 3.16 (1.33–7.55) 0.0095
Model 2
6 live births 3.40 (1.13–10.2) 0.0295
Adiponectin
(log) 0.42 (0.20–0.89) 0.0234
Family history
of diabetes 4.35 (1.95–9.73) 0.0003
Hypertension 2.99 (1.26–7.07) 0.0128
Data are adjusted for age, education, estrogen use,
and VAT. Model 1: parity as a continuous variable;
model 2: by parity category, with low parity (1–2
births) as the referent group.
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family history of type 2 diabetes, parity re-
mainedindependentlyassociatedwithtype
2 diabetes (adjusted OR 1.22 [95% CI
1.03–1.44],P0.021)afteradjustmentfor
adiponectin, VAT, age, education, estrogen
use, and hypertension.
CONCLUSIONS — This highly par-
ous cohort of nonobese Filipino Ameri-
can women with elevated diabetes
prevalence offered a unique opportunity
to assess the association between multi-
parity and type 2 diabetes. Prior studies
have identiﬁed postpartum weight reten-
tion as the primary mechanism for type 2
diabetes in multiparous women (1,2);
however, to our knowledge, no studies
have included computed tomography–
deﬁnedVATmeasures,adipokines,orgh-
relin. Although anthropometric markers,
includingVAT,increasedwithparity,vis-
ceral adiposity did not explain the excess
diabetes prevalence among grand multip-
arous women. Low adiponectin con-
centration and hypertension were inde-
pendently associated with type 2 diabetes,
aswasfamilyhistoryofdiabetes,reinforc-
ing the important contribution of genetic
factors; however, the excess diabetes
prevalence in grand multiparous women
persistedwhentheanalysiswaslimitedto
those without a family history of type 2
diabetes.
Physical inactivity did not differ by
parity group, contrary to other observa-
tions. Our observations of decreasing ed-
ucation and estrogen use with increasing
parity is consistent with prior studies (3),
but neither was independently associated
with type 2 diabetes. However, this co-
hortwashighlyeducated,andalmosthalf
were college graduates, including 22% of
grand multiparous women. Conse-
quently, we were unable to observe the
confounding effects of education and so-
cioeconomic status on lifestyle behaviors
and diabetes risk associated with higher
parity in prior studies (5).
Pregnancy is a diabetogenic state
characterized by adipose tissue accretion,
hyperinsulinemia, insulin resistance, li-
polysis,elevatedleptinandresistinlevels,
and reduced adiponectin secretion (22).
Multiple pregnancies result in longer cu-
mulative exposure to insulin resistance
and hypoadiponectinemia. It remains
unclear whether these conditions are
sustained or exacerbated postpartum
through middle-age. Low adiponectin
was independently associated with type 2
diabetes in this analysis, and levels were
signiﬁcantly lower in multiparous
women, but neither insulin resistance (by
HOMA-IR) nor leptin concentration dif-
fered by parity group.
Gestational diabetes mellitus (GDM)
is a risk factor for future incident type 2
diabetes (23), but GDM history was not
ascertained in this study because the ma-
jority (88%) of women gave birth before
1979,whenGDMbecameaclinicallyrec-
ognized entity. Despite the general ab-
senceofpreconceptionalobesity,Filipino
Americanparturientshavethethirdhigh-
est GDM prevalence (7.1%) in the U.S.,
following Asian Indians (8.6%) and Pa-
ciﬁc Islanders (7.4%), and have higher
GDM prevalence than Native American,
Caucasian,AfricanAmerican,orHispanic
parturients (24). Women in our cohort
might have had a similarly elevated prev-
alence of GDM during multiple pregnan-
cies, consequently exacerbating their risk
for type 2 diabetes.
Study limitations included enroll-
ment of a volunteer sample because cen-
sus data during study enrollment
reported Asian-American nationalities
collectively, such that population-based
sampling of Filipinos was not possible.
However, college completion in our co-
hort was identical to that in the 2000
nationalcensusdataforallFilipinoAmer-
ican women aged 25 years; suggesting
that our sample was generalizable to all
Filipino American women with regard to
socioeconomic status. Additional consid-
erations include the small sample sizes
when stratiﬁed into parity categories, as
reﬂected by the wide CIs in multivariable
regression analysis. Total adiponectin,
rather than the different isomers of adi-
ponectin, was measured; the high-
molecular-weight form of adiponectin is
substantially reduced in GDM (25), al-
though it remains unclear whether high-
molecular-weight adiponectin accounts
for the elevated diabetes risk in grand
multiparity. Furthermore, we did not in-
clude fetal losses, where long gestations
that terminated spontaneously or as still-
births contributed to the cumulative dia-
betogenic exposure during pregnancy.
Finally, the generalizability of our ﬁnd-
ings to other highly parous populations is
questionable, given the elevated preva-
lenceoftype2diabetes,GDM,familyhis-
tory of type 2 diabetes, excess VAT
accumulation, and low adiponectin con-
centration among Filipino American
women (20,21,24).
The strengths of this study include
useofacohortofhighlyparouswomenof
whom one-third had type 2 diabetes and
one-fourth had grand multiparity. Use
of computed tomography–deﬁned VAT
allowsmorepreciseenumerationofintra-
abdominal obesity compared with esti-
mates provided by BMI or waist in prior
studies.Toourknowledge,thisistheﬁrst
study to assess the role of adiponectin,
leptin, and ghrelin as mechanisms for
theassociationbetweenmultiparityand
diabetes. None of the women were us-
ing thiazolidinediones, which enabled
comparisons by parity group without
the confounding effects of medications
that can alter adiponectin or ghrelin
levels.
In summary, grand multiparity was
associated with type 2 diabetes, indepen-
dentofvisceraladiposityandadiponectin
concentration. Hypertension, family his-
tory of diabetes and low adiponectin lev-
els were also associated with type 2
diabetes but did not explain the excess
diabetes prevalence in grand multiparous
women. Grand multiparity may exacer-
bate diabetes risk through myriad mech-
anisms that have yet to be identiﬁed.
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